Source Fact: Financial Supervisory Service DART / 2025-07-21
Disclosure Type: Report on Major Corporate Decisions (Decision on Share Buyback)
💡 3-Second Summary
Celltrion has decided to purchase 554,632 common shares directly on the market for approximately KRW 100 billion to stabilize its stock price and enhance shareholder value.
📊 1. [Key Disclosure Details & Major Figures]
- Estimated Number of Shares to Acquire: 554,632 Common Shares
- Estimated Acquisition Amount: KRW 100,000,149,600 (Approx. KRW 100B)
- Based on the closing price of KRW 180,300 on July 18, 2025 (the day prior to the Board of Directors’ decision date). The actual acquisition amount may change depending on stock price fluctuations.
- Expected Acquisition Period: July 22, 2025 ~ October 21, 2025 (Expected holding period is at least 6 months from the final acquisition date)
- Purpose of Acquisition: Stock price stabilization and enhancement of shareholder value
- Method of Acquisition: Direct on-market purchase through the KRX (KOSPI) market
- Entrusted Investment Brokers: NH Investment & Securities, Meritz Securities
- Daily Purchase Limit: 126,081 Common Shares
- Treasury Share Status Prior to Current Buyback:
- Acquired within the distributable profit limit: 6,040,434 shares (2.6%)
- Other acquisitions: 5,182,369 shares (2.2%)
- Total: 11,222,803 shares
📈 2. [Expert Perspective: What This Means for Investors]
This announcement reflects Celltrion’s corporate action to utilize its internal funds to purchase its own shares directly from the open market to boost shareholder returns. A buyback worth approximately KRW 100 billion is highly likely to act as a solid shock absorber for the stock price in the short term, as it introduces a reliable, large-scale buyer to the market. With a daily purchase limit of 126,081 shares, a consistent influx of buying demand is anticipated over the designated three-month buyback period.
From a financial health perspective, this decision is highly sustainable. Celltrion’s legally permissible limit for share buybacks (based on the commercial law’s distributable profit limit) stands at an ample KRW 4.38T (trillion). Thus, executing a buyback of KRW 100B (billion) represents a low-risk capital allocation that does not strain the company’s financial structure. However, unless these purchased treasury shares are permanently cancelled (retired), the long-term impact on boosting earnings per share (EPS) might be limited, as they merely reduce floating supply temporarily.
📝 Editor’s Comment (by K-STOCK Editor)
Celltrion’s decision to buy back its own shares once again confirms the management’s strong commitment to active defensive maneuvers during periods of market uncertainty. This move sends a clear signal to market participants that the current stock price is perceived by the company as undervalued compared to its intrinsic corporate value.
Going forward, global investors should focus on two key variables. First is whether this buyback will eventually lead to actual “share retirement.” Treasury shares that are simply held on the balance sheet can always be re-introduced to the market in the future, meaning they represent a potential overhang risk unless they are permanently deleted.
Second is the actual pace and execution of the daily buybacks during the designated period (July 22 – October 21). While these open-market purchases serve as a temporary downside cushion for the stock price, the true driver for sustainable mid-to-long-term valuation will remain the fundamentals of the company’s core business—specifically, its new biosimilar approvals and global sales growth.
📢 Disclaimer & Source
Source: This content has been structured and rewritten based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.
Inquiries: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
